Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hugan keli
- Development stage
- Unknown
- Lead developer
- Taiji Group
- Administration
- Oral
01
Overview
Hugan Granules (Hugan Keli) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Taiji Group Chongqing Fuling Pharmaceutical Factory. It is an approved medication in China indicated for the treatment of various liver disorders, including chronic hepatitis and early-stage cirrhosis. The formula is composed of six primary ingredients: *Schisandra chinensis* (Wuweizi), *Bupleurum chinense* (Chaihu), *Artemisia capillaris* (Yinchen), *Isatis tinctoria* (Banlangen), pig bile powder (Zhu Danfen), and mung bean (Lvdou). These components work synergistically to provide hepatoprotective effects, promote bile secretion, and reduce serum transaminase levels (ALT/AST). Hugan Granules is widely utilized for its ability to soothe the liver, strengthen the spleen, and support the regeneration of liver tissue in patients with inflammatory or toxic liver damage.
- Brand names
- Hugan Granules护肝颗粒
- Other names
- Hugan Keli
Beyond the preview
Go deeper on hugan keli.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hugan keli.